Wednesday, 27th August The Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology 2014

7:00AM - 8:30AM
Organiser Office 5.101
7:00AM - 8:30AM
Meeting Room 217
Sponsored by:

In an attempt to better manage overweight and obesity to help prevent diabetes and other diseases, there is much focus on reducing body weight, body fat and the risk of metabolic disease, with little attention to possible long-term adverse effects of weight loss interventions. However, with the expansion of obesity in all age groups in Australia and other countries, as well as increasing life expectancy, it is important to consider potential long-term effects of diet-induced weight loss and energy restriction. Of particular concern are the potential adverse effects of these obesity interventions on neuroendocrine status and body composition.

Energy deficit in lean or obese animals or humans stimulates appetite and reduces energy expenditure, thereby contributing to weight regain. Often overlooked in obesity interventions, however, is the effect of energy restriction on neuroendocrine status, and the impact this could have on body composition and strength.

This breakfast session covers hypothalamic pathways that could influence bone mass and muscle strength during diet-induced weight loss in overweight or obese humans and animals, notably via effects on circulating concentrations of hormones such as peptide YY or cortisol. It also highlights gaps in current knowledge and ideas for future research efforts.

As our population becomes increasingly obese, from a younger age, with more people using weight management strategies for longer, this line of enquiry could guard against inadvertent increases in frailty, fractures and loss of independence in our ageing population.

Topics covered:         

  • Effects of energy restriction on neuroendocrine status in overweight or obese animals and humans.
  • Effects of diet-induced weight loss on bone mass or muscle strength in overweight or obese adults.
  • Mechanisms by which neuropeptides or hormones that regulate appetite and glucose homeostasis regulate bone mass in mice.


 Assoc Prof Amanda Salis and team (Ms Jessica Zibellini, Ms Amy D Nguyen)

8:30AM - 9:15AM
Plenary Hall 2
Chair: Morton Burt
9:30AM - 11:00AM
Meeting Room 213
Chairs: Mark McLean & Katherine Benson
10:00AM - 11:00AM
Meeting Room 212
Chair: Eileen McLaughlin
Sponsored by:
11:00AM - 11:30AM
Exhibition Area
11:00AM - 12:00PM
Organiser Office 5.101
11:30AM - 1:00PM
Meeting Room 219
Chairs: Mark Cooper & Christian Girgis
Sponsored by:
1:00PM - 2:00PM
Exhibition Area
1:00PM - 2:00PM
Hospitality Suite 5.201 & 5.202
1:15PM - 2:00PM
Meeting Room 217
Chair: Christopher Ormandy
2:00PM - 3:30PM
Meeting Room 212

14:00 Introduction S Andrikopoulos

14:05 The art of scientific writing P Ebeling

14:20 The peer review process D Wilhelm

14:35 Responding to reviewer comments J Greenfield

14:50 Publishing ethics: Fabrication, Falsification and Plagiarism A Clark

15:05 Questions and discussion

2:00PM - 3:30PM
Meeting Room 213
Chairs: Sue Mei Lau & Jenny Gunton
Sponsored by:
2:00PM - 5:30PM
Meeting Room 216

2:00-2:15         Dr Kelly Walton (MIMR-PHI): “Generating specific TGF-b superfamily antagonists”

2:15-2:30         Dr Paul Gregorevic (Baker IDI): "Exploring Bone Morphogenetic Protein signalling as a positive regulator of skeletal muscle in health and disease"

2:30-2:45         Prof Frank Lovicu (University of Sydney): "Regulation of TGF-b for maintenance of lens and prevention of cataract."

2:45-3:00         Prof Ray Rodgers (Robinson Research Institute): “TGF-b and polycystic ovary syndrome”

3:00-3:15         Dr Phillip Kantharidis (Baker IDI): “TGF-b regulated microRNA in diabetic nephropathy”

3:15-3:30         Alistair Cole (PhD Student, University of Melbourne): “The Role of BMP Signalling in Oligodendrocyte Differentiation and Myelin Repair”

5 min break

3:35-3:50         Prof Peter Koopman (University of Queensland): “Nodal signalling in male germ cell development and testicular cancer”

3:50-4:00         Prof Kate Loveland (Monash University): “Hanging drop cultures reveal activin regulation of a key signalling molecule in human testicular germ cell tumours”

4:00-4:15         Dr Kaye Stenvers (MIMR-PHI): “TGFBR3 in reproductive development and cancer”

4:15-4:30         Dr Hitesh Peshavariya (Centre for Eye Research Australia): “Transforming growth factor-β1 requires NADPH oxidase-derived redox signalling for neovascularization”

4:30-4:45         Dr Hong-Jian Zhu (University of Melbourne): “Double edged sword: TGF-b signalling in breast cancer metastasis and implication in targeted therapy”

4:30-4:45         Prof David de Kretser (MIMR-PHI/Monash University): “The potential uses of follistatin in organ transplantation”

4:45-5:00         Dr Vicky Tsai (St Vincent’s Centre for Applied Medical Research): “MIC-1/GDF15, role in physiological and pathological regulation of appetite and body weight”

3:30PM - 4:30PM
Meeting Room 212
Chair: Belinda Henry